Oct 18, 2021 8:17am EDT HAMID ERFANAIN NAMED CHIEF EXECUTIVE OFFICER OF ENZO BIOCHEM TO ACCELERATE EXPANSION AND COMMERCIALIZATION OF KEY DIAGNOSTIC PLATFORMS
Oct 12, 2021 7:00am EDT Enzo Biochem Reports Fourth Quarter and Fiscal Year 2021 Financial Results and Provides Business Update
Sep 28, 2021 8:00am EDT Enzo Biochem to Report Fourth Quarter and Full Year 2021 Financial Results and Business Update on Tuesday, October 12th
Sep 02, 2021 4:05pm EDT ENZO BIOCHEM TO PRESENT AT THE H.C. WAINWRIGHT 23RD ANNUAL GLOBAL INVESTMENT CONFERENCE
Jul 20, 2021 8:00am EDT ENZO BIOCHEM RECEIVES FDA EMERGENCY USE AUTHORIZATION FOR RAPID EXTRACTION METHOD ON PROPRIETARY TEST SYSTEM FOR DETECTION OF CORONAVIRUS SARS-CoV-2
Jun 15, 2021 12:00pm EDT Enzo Biochem Announces Online Service with TrustAssure to Schedule Timely PCR Testing Required for International Travel
Jun 01, 2021 4:05pm EDT Enzo Biochem to Report Third Quarter 2021 Financial Results on Wednesday, June 9
Apr 21, 2021 8:00am EDT Enzo’s Universal AMPICOLLECT™ Used on GENFLEX® Molecular Platform Cleared for Distribution by FDA Under Emergency Use Authorization
Mar 17, 2021 4:15pm EDT ENZO BIOCHEM TO PRESENT AT THE KEYBANC CAPITAL MARKETS' LIFE SCIENCES & MEDTECH INVESTOR FORUM
